Targeting the incretin system in obesity and type 2 diabetes mellitus
Nature Reviews Endocrinology – This article reviews advances in incretin-based pharmacotherapy, including the latest glucagon-like peptide 1 (GLP1) receptor agonists (GLP1RAs), ‘GLP1…